NAD+
METABOLISM - DIABETES - WEIGHT LOSS



Regen Med Asia / Products – NAD+ / Metabolism
Metabolism
Metabolic disorders such as Diabetes and Obesity are a growing concern and very difficult to address for many people. These conditions can lead to serious health issues and side effects such as cardiovascular disease, peripheral artery disease, atherloscerosis, arthritis and blindness. Drugs can often help with symptoms but the underlying causes and pathologies are not easily treated.
Mitochondrial dysfunction has been studied for these conditions and published peer reviewed research has shown clear linkages to Sirtuins and their activity. Supplementation with NAD+ in animal models has shown significant improvements from many different Universities and Insititutions.


- Weight Loss
Recent Studies

Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases
The below research paper from Harvard University has a broad overview of research on how NAD+ can be used for various metabolic conditions.

Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice
This research paper discuss Type 2 diabetes and how NAD+ biosynthesis is crtical to the process as well as supplementation outcomes.

Maternal Nicotinamide Riboside Enhances Postpartum Weight Loss, Juvenile Offspring Development, and Neurogenesis of Adult Offspring
This research shows clear evidence in mice of NAD+ effects on offspring development, brain development and benefits to mothers that supplemented.


These statements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. These results are not typical. Individual results may vary.